Lupus anticoagulants are a heterogeneous group of autoantibodies directed against hemostatically active phospholipids and phospholipid-protein complexes. The presence of lupus anticoagulants can predispose to thrombosis and recurrent abortion. Both arterial and venous thrombosis have been described. Reduced anticoagulant activity of activated protein C has been discussed as a possible pathophysiologic mechanism. Various functional and immunologic tests are available for detecting lupus anticoagulants. The definitive diagnosis of a lupus anticoagulant requires a positive result in two independent functional tests or the simultaneous detection of a lupus anticoagulant in one functional and one immunologic test. Treatment aims at the prevention of thromboembolic complications, so patients should remain on oral anticoagulation until lupus anticoagulant parameters have normalized.
KeywordsHeparin Hexagonal Luminal Thrombocytopenia Prothrombin
Unable to display preview. Download preview PDF.
- 3.Conley CL, Hartmann R (1952) Hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 150: 621–622Google Scholar
- 5.Feinstein DI (1982) Lupus anticoagulant, anticardiolipin antibodies, fetal loss, and systemic lupus erythematosus. Blood 80: 859–862Google Scholar
- 7.Mueller JF, Ratnoff O, Heinle RW (1951) Observations on the characteristics of an unusual circulating anticoagulant. Lab Clin Med 38: 254–261Google Scholar
- 9.Pötzsch B, Kawamura H, Preissner KT et al (1992) Thrombophilia in patients with lupus anticoagulant correlates with impaired anticoagulant activity of activated protein C but not with decreased activation of protein C. Blood 80: 267a (Abstract)Google Scholar